HHG & Company’s Pfizer PFE Stock Holding History

HHG & Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$11M	Sell	390,922 -7,190	-2%	-$205K	3.05%	4
2015 Q4	$12.2M	Buy	398,112 +1,618	+0.4%	+$50.9K	3.29%	4
2015 Q3	$11.8M	Buy	396,494 +16,201	+4%	+$519K	3.59%	3
2015 Q2	$12.1M	Sell	380,293 -1,276	-0.3%	-$41.6K	3.49%	4
2015 Q1	$12.6M	Sell	381,569 -3,371	-0.9%	-$107K	3.31%	4
2014 Q4	$11.4M	Buy	384,940 +80,120	+26%	+$2.3M	2.72%	5
2014 Q3	$8.55M	Sell	304,820 -161,240	-35%	-$4.53M	2.79%	4
2014 Q2	$13.1M	Buy	466,060 +18,575	+4%	+$529K	4.27%	2
2014 Q1	$13.6M	Buy	447,485 +3,418	+0.8%	+$102K	4.66%	1
2013 Q4	$12.9M	Buy	444,067 +171,015	+63%	+$4.98M	4.78%	1
2013 Q3	$7.44M	Buy	273,052 +7,166	+3%	+$195K	2.99%	2
2013 Q2	$7.07M	Buy	+265,886	New	+$7.35M	2.85%	4

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

HHG & Company's PFE Position: Q1 2016 in Review

HHG & Company reduced its Pfizer (PFE) stake by 1.8% in Q1 2016, selling an estimated $205K and leaving 390,922 shares worth $11M. The position accounts for 3.05% of the portfolio, ranked #4.

HHG & Company first reported a position in PFE in Q2 2013 and has held it in 12 quarters since. The position peaked at $13.6M in Q1 2014. 1,969 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

HHG & Company held 390,922 shares of Pfizer worth $11M as of Q1 2016.
HHG & Company sold 7,190 Pfizer shares in Q1 2016, an estimated $205K.
Pfizer made up 3.05% of HHG & Company's portfolio in Q1 2016, its #4 holding.
HHG & Company first reported a position in Pfizer in Q2 2013 and has held it in 12 quarters since.
HHG & Company's Pfizer position peaked at $13.6M in Q1 2014.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on HHG & Company's 13F filing for Q1 2016, filed 20 Apr 2016.